36E79720R0038-001.docx
DOCX document Posted
- Attached to
- 6505--Bevacizumab Federal contract opportunity
- Solicitation number
- 36E79720R0038
About this file
This notice announces a pre-solicitation for Request for Proposal 36E79720R0038 to procure an unrestricted supply of Bevacizumab for the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The contract will have a one year base period and four one-year option periods. Offerors must provide the exact brand name and National Drug Code number for the drug to be supplied. The solicitation will be issued electronically on May 21, 2020 with responses due by June 4, 2020. The estimated annual requirements are 35,277 vials of 100mg Bevacizumab and 8,034 vials of 400mg Bevacizumab. Questions can be emailed to the point of contact Stevan Vasich by the response deadline.
36E79720R0038 36E79720R0038_1.docx
View the file
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Contract Opportunity Presolicitation Notice
CLASSIFICATION CODE
SUBJECT
CONTRACTING OFFICE'S
ZIP-CODE
SOLICITATION NUMBER
RESPONSE DATE (MM-DD-YYYY)
ARCHIVE
DAYS AFTER THE RESPONSE DATE
RECOVERY ACT FUNDS
SET-ASIDE
NAICS CODE
CONTRACTING OFFICE
ADDRESS
POINT OF CONTACT
(POC Information Automatically Filled from User Profile Unless Entered)
DESCRIPTION
See Attachment
AGENCY'S URL
URL DESCRIPTION
AGENCY CONTACT'S EMAIL
ADDRESS
EMAIL DESCRIPTION
ADDRESS
POSTAL CODE
COUNTRY
ADDITIONAL INFORMATION
GENERAL INFORMATION
PLACE OF PERFORMANCE
* = Required Field Contract Opportunity Presolicitation Notice Bevacizumab 60141 36E79720R0038 06-04-2020 N 325412 Stevan Vasich Email: Stevan.Vasich@va.gov Phone: 708-786-5969 Stevan.Vasich@va.gov Stevan.Vasich@va.gov PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79720R0038 for an unrestrictive procurement Bevacizumab, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA’s and DOD’s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation #36E79720R0038 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about May 21st, 2020, with a tentative closing date of June 4th, 2020. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download on Contract Opportunities at the following URL: https://beta.sam.gov/search?index=opp. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Stevan Vasich. Questions can be e-mailed to: Stevan.Vasich@.gov.
The estimated annual requirements are as follows:
| Item |
| Description |
| Package Size (Vials) |
| Estimated Annual Requirements (Vials) |
| 1a |
| Bevacizumab 100 MG |
| 1 |
| 35,277 |
OR
| 2a |
| Bevacizumab-AWWB 100MG |
| 1 |
OR
| 3a |
| Bevacizumab-BVZR 100 MG |
| 1 |
| 1b |
| Bevacizumab 400 MG |
| 1 |
| 8,034 |
OR
| 2b |
| Bevacizumab-AWWB 400 MG |
| 1 |
OR
| 3b |
| Bevacizumab-BVZR 400 MG |
| 1 |
*Offers are required to include individual vials in both strengths (100MG and 400MG), but also include any other case sizes offered commercially for both strengths. Offerors must propose all commercial outer packs at the same price/vial as the individual price/vial. The estimated number of vials (i.e. 35,277 for 100MG and 8,034 for 400MG) is for the individual vials per strength. Additional pack sizes (e.g. pack of 10 vials) do not change the required number of vials.
Page 1 of
File details come from the government source that posted it. Updated .